Comparative efficacy of fenofibrate/pravastatin/ezetimibe and simvastatin/ezetimibe therapies in type 2 diabetic patients with combined hyperlipidaemia and cardiovascular disease

被引：0
|
作者：
Farnier, M. [1 ]
Steinmetz, A. [2 ]
Csaszar, A. [3 ]
Retterstol, K. [4 ]
Dluzniewski, M. [5 ]
机构：
[1] Point Med, Dijon, France
[2] St Nikolaus Stiftshosp GmbH, Andernach, Germany
[3] State Hlth Ctr, Budapest, Hungary
[4] Oslo Univ Hosp Rikshosp, Oslo, Norway
[5] Warsaw Hosp, Warsaw, Poland
来源：
DIABETOLOGIA | 2010年 / 53卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1296
引用
收藏
页数：1
相关论文
共 50 条
  • [41] The safety and efficacy of ezetimibe/simvastatin (E/S) versus atorvastatin (A) in hypercholesterolaemic (HC) patients with type 2 diabetes (T2DM)
    Mazzone, T.
    Goldberg, R. B.
    Guyton, J. R.
    Weinstock, R. S.
    Polis, A.
    Gazzara, R. A.
    Tomassini, J. E.
    Tershakovec, A. M.
    DIABETOLOGIA, 2006, 49 : 748 - 748
  • [42] Therapeutic practice patterns related to statin potency and ezetimibe/simvastatin combination therapies in lowering LDL-C in patients with high-risk cardiovascular disease
    Toth, Peter P.
    Foody, JoAnne M.
    Tomassini, Joanne E.
    Sajjan, Shiva G.
    Ramey, Dena R.
    Neff, David R.
    Tershakovec, Andrew M.
    Hu, Henry
    Tunceli, Kaan
    JOURNAL OF CLINICAL LIPIDOLOGY, 2014, 8 (01) : 107 - 116
  • [43] Attainment of cholesterol goals with Fenofibrate 160 mg/Pravastatin 40 mg Therapy in Type 2 Diabetic patients with combined hyperlipidemia in primary prevention, not at goal on Simvastatin 20 mg
    Farnier, M.
    Dluzniewski, M.
    Csazar, A.
    Steinmetz, A.
    Retterstol, K.
    EUROPEAN HEART JOURNAL, 2010, 31 : 390 - 390
  • [44] Ezetimibe Ameliorates Cardiovascular Complications and Hepatic Steatosis in Obese and Type 2 Diabetic db/db Mice
    Fukuda, Masaya
    Nakamura, Taishi
    Kataoka, Keiichiro
    Nako, Hisato
    Tokutomi, Yoshiko
    Dong, Yi-Fei
    Yasuda, Osamu
    Ogawa, Hisao
    Kim-Mitsuyama, Shokei
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2010, 335 (01): : 70 - 75
  • [45] COMPARATIVE EFFICACY AND SAFETY OF MICRONIZED FENOFIBRATE AND SIMVASTATIN IN PATIENTS WITH PRIMARY TYPE IIA OR IIB HYPERLIPIDEMIA
    FARNIER, M
    BONNEFOUS, F
    DEBBAS, N
    IRVINE, A
    ARCHIVES OF INTERNAL MEDICINE, 1994, 154 (04) : 441 - 449
  • [46] Efficacy of Ezetimibe is Associated with Gender and Baseline Lipid Levels in Patients with Type 2 Diabetes
    Shigematsu, Erina
    Yamakawa, Tadashi
    Taguri, Masataka
    Morita, Satoshi
    Tokui, Mikiya
    Miyamoto, Kazunori
    Funae, Osamu
    Takatuka, Yoji
    Kadonosono, Kazuaki
    Shigematsu, Hiroshi
    Terauchi, Yasuo
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2012, 19 (09) : 846 - 853
  • [47] Oxidative stress influenced by simvastatin or fenofibrate treatment in Type 2 diabetic patients with dyslipidemia
    Prazny, M
    Skrha, J
    Hilgertová, J
    Weiserová, H
    DIABETOLOGIA, 2003, 46 : A355 - A356
  • [48] The long-term safety and efficacy of combined simvastatin and fenofibrate therapy in diabetic patients with dyslipidemia: The DIACOR study
    May, Heidi T.
    Pearson, Robert R.
    Jensen, Jonathan R.
    Horne, Benjamin D.
    Anderson, Jeffrey L.
    Whetstone, Jamie M.
    Muhlestein, Joseph B.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 49 (09) : 344A - 344A
  • [49] The Combination Therapy of Fenofibrate and Ezetimibe Improved Lipid Profile and Vascular Function Compared with Statins in Patients with Type 2 Diabetes
    Shinnakasu, Atsushi
    Yamamoto, Kiyoaki
    Kurano, Mihoko
    Arimura, Hiroshi
    Arimura, Aiko
    Kikuti, Akira
    Hashiguchi, Hiroshi
    Deguchi, Takahisa
    Nishio, Yoshihiko
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2017, 24 (07) : 735 - 748
  • [50] Lipid-altering efficacy and safety of ezetimibe/simvastatin coadministered with extended-release niacin in patients with type IIa or type IIb hyperlipidemia
    Guyton, John R.
    Brown, B. Greg
    Fazio, Sergio
    Polis, Adam
    Tomassini, Joanne E.
    Tershakovec, Andrew M.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (16) : 1564 - 1572
12345